CREFMIRLIMAB

UNII:	PTO7SXB9L7
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	CREFMIRLIMAB
GSRS Full Record:	PTO7SXB9L7 i

2611099-93-3
CREFMIRLIMAB [USAN]
IAB22M2C
IAB22M2C (ANTIBODY FRAGMENT AGAINST THE HUMAN CD8-ANTIGEN ON CD8-POSITIVE T-CELLS)
IMAGINAB
IMMUNOGLOBULIN, ANTI-(HUMAN CD8A ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL IAB22M2 .KAPPA.-CHAIN V-J REGION) FUSION PROTEIN WITH PEPTIDE LINKER (GSTSGGGSGGGSGGGGSS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD8A ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL IAB22M2 HEAVY CHAIN V-D-J REGION) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (SYNTHETIC .GAMMA.1-CHAIN HINGE REGION) FUSION PROTEIN WITH PEPTIDE LINKER (GGGSSGGGSG) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (DE-C-TERMINAL LYSINE) (HUMAN .GAMMA.1-CHAIN CH3 REGION), DIMER
crefmirlimab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CREFMIRLIMAB

Synonyms and Mappings

Resources